A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Solid Tumors

Interventions

DRUG

ABT-869

2.5mg \[5 mg days 1, 8 and 12. 17.5 mg on days 13 and after\]

DRUG

ketoconazole

400 mg days 6-11

Trial Locations (2)

Site Reference ID/Investigator# 35784, Detroit

Site Reference ID/Investigator# 36527, Lebanon